Delivery Order SPE2DB20D3103-SPE2DB24FM5B4

Award Date 1/31/24
Potential Completion Date 2/1/24
Potential Value $2.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $13,857.65 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 130 mg/mL vials of the pharmaceutical Phenobarbital. This delivery order was issued under an Indefinite Delivery Contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,089.00, is for the delivery of 4568079011 PHENOBARBITAL 65 MG/ML VIALML. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,243.84, is for the delivery of PHENOBARBITAL 130 MG/ML VIALML. This is a firm fixed price delivery order contract with a completion date of March 13, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,924.30, is for the delivery of PHENOBARBITAL 65 MG/ML VIALML. The contract is a firm-fixed-price Delivery Order with an ultimate completion date of August 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,938.32 fixed-price delivery order is for the supply of Phenobarbital 130 mg/mL vials. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,008.66 firm fixed-price delivery order is for the supply of 4567243104 PHENOBARBITAL 65 MG/ML VIALML, a pharmaceutical product. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568161338 - Phenobarbital 65 mg/ml vial. The $3,905.64 firm fixed-price contract has a completion date of May 7, 2025. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Phenobarbital 130 mg/mL vials. The contract has a ceiling value of $1,963.18 and runs through March 25, 2025. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 65 mg/ml PHENOBARBITAL vials. The contract is a firm fixed-price delivery order with a ceiling value of $1,293.27 and a period of performance ending on May 23, 2025. The award is not designated as a set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Phenobarbital 130 mg/ml vials. The contract is a Delivery Order with a Firm Fixed Price of $7,906.95 and a period of performance ending on July 30, 2024. The contract does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, will provide these essential pharmaceutical products to support...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FM5B4
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,436.92 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of PHENOBARBITAL 65 MG/ML VIAL. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was awarded solely to Amerisourcebergen Drug Corp, with a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.

Generated 5/1/24, 10:07 AM